Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Miller

Showing results (41-50 of 313) with videos related to

Pageof 32
Sort By:
International Journal of Andrology|May 14, 2004
Expression of the apoptosis inhibitor survivin in testicular tissue of infertile patientsSteffen Weikert, Mark Schrader, Markus Müller, et al.
Oncology|September 2, 2003
Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patientsBernd Straub, Markus Müller, Hans Krause, et al.
Clinical Chemistry|October 30, 2008
Circulating matrix metalloproteinase-7: an early or metastatic marker for renal cell carcinoma?Klaus Jung, Azizbek Ramankulov, Mark Schrader, et al.
Health Policy (Amsterdam, Netherlands)|May 19, 2005
Paper tigers--do clinical guidelines improve health care quality in patients with testicular germ cell tumors in Germany?Mark Schrader, Lothar Weissbach, Steffen Weikert, et al.
The Journal of Urology|March 22, 2008
Re: Application of artificial intelligence to the management of urological cancer. M. F. Abbod, J. W. Catto, D. A. Linkens and F. C. Hamdy J Urol 2007; 178: 1150-1156Carsten Stephan, Henning Cammann, Michael Lein, et al.
Urologie (Heidelberg, Germany)|August 12, 2024
[Digital health applications in urology]Sandra Schönburg, Christian Gratzke, Kurt Miller, et al.
Aktuelle Urologie|April 14, 2017
[Interdisciplinary Recommendations for the Treatment of Metastatic Renal Cell Carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Rare Tumors|December 9, 2010
Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to dateJan Ebbing, Carolin Blind, Harald Stein, et al.
Oncology Reports|November 15, 2011
Expression of endothelial factors in prostate cancer: a possible role of caveolin-1 for tumour progressionIsabel Steiner, Klaus Jung, Kurt Miller, et al.
European Urology|December 31, 2010
Bone turnover markers as predictors of mortality risk in prostate cancer patients with bone metastases following treatment with zoledronic acidKlaus Jung, Kurt Miller, Manfred Wirth, et al.
Pageof 32

Showing results (41-50 of 313) with videos related to

Sort By:
Pageof 32
International Journal of Andrology|May 14, 2004
Expression of the apoptosis inhibitor survivin in testicular tissue of infertile patientsSteffen Weikert, Mark Schrader, Markus Müller, et al.
Oncology|September 2, 2003
Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patientsBernd Straub, Markus Müller, Hans Krause, et al.
Clinical Chemistry|October 30, 2008
Circulating matrix metalloproteinase-7: an early or metastatic marker for renal cell carcinoma?Klaus Jung, Azizbek Ramankulov, Mark Schrader, et al.
Health Policy (Amsterdam, Netherlands)|May 19, 2005
Paper tigers--do clinical guidelines improve health care quality in patients with testicular germ cell tumors in Germany?Mark Schrader, Lothar Weissbach, Steffen Weikert, et al.
The Journal of Urology|March 22, 2008
Re: Application of artificial intelligence to the management of urological cancer. M. F. Abbod, J. W. Catto, D. A. Linkens and F. C. Hamdy J Urol 2007; 178: 1150-1156Carsten Stephan, Henning Cammann, Michael Lein, et al.
Urologie (Heidelberg, Germany)|August 12, 2024
[Digital health applications in urology]Sandra Schönburg, Christian Gratzke, Kurt Miller, et al.
Aktuelle Urologie|April 14, 2017
[Interdisciplinary Recommendations for the Treatment of Metastatic Renal Cell Carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Rare Tumors|December 9, 2010
Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to dateJan Ebbing, Carolin Blind, Harald Stein, et al.
Oncology Reports|November 15, 2011
Expression of endothelial factors in prostate cancer: a possible role of caveolin-1 for tumour progressionIsabel Steiner, Klaus Jung, Kurt Miller, et al.
European Urology|December 31, 2010
Bone turnover markers as predictors of mortality risk in prostate cancer patients with bone metastases following treatment with zoledronic acidKlaus Jung, Kurt Miller, Manfred Wirth, et al.
Pageof 32